K-RAS is the isoform most frequently mutated and in addition to being almost inevitably mutated in pancreatic cancers, K-RAS mutations are present in approximately half of colorectal cancers and a third of lung cancers[3]. This evidence concerns the gene KRAS and lung cancer.